Search

Background: The European Vascular Surgeons in Training (EVST) were appointed by the European Society for Vascular Surgery to review the current status and developments regarding training and certification in vascular surgery (VS) across Europe. Methods: An e-mail-based survey was distributed to EVST representatives in 33 countries. The questionnaire examined the current structure of vascular surgery training and certification (monospecialty, subspecialty, no specialty), as well as the evolving revisions of national curricula. Questionnaires were returned from 31 countries, two of which implement two training models. Results: Vascular surgery (VS) as a monospecialty is the leading training model in 18 out of 31 countries, nine countries follow the subspecialty model, and six countries have no accredited vascular programs. The mean duration of dedicated VS training in monospecialty is significantly longer compared with subspecialty (3.8 vs. 2.9 years, p = .036) or no specialty models (3.8 vs. 1 years, p < .001). 83% of countries implementing an independent certification have recently updated their training curriculum; the respective rates for countries implementing a subspecialty or no specialty model are 56% and 17%. Among countries that offer VS certification, the endovascular logbook is mandatory in 78%, quality control of training centers or trainers is implemented in 62%, and training centers are reported as heterogeneous in 46%. The Working Time Directive is followed by vascular trainees in 10/24 EU countries. Conclusions: The results of this survey represent the most updated detailed record of the European training profiles in VS and document the diversity of vascular training across Europe. [Copyright &y& Elsevier]

Summary: The expression of receptor for androgen (AR), oestrogen α and β (ERα and ERβ) and progesterone (PR) was examined immunohistochemically in canine prostate specimens (normal, hyperplastic, inflamed [prostatitis] or neoplastic). AR immunolabelling was seen in 100% of epithelial cells of normal and hyperplastic tissue, the corresponding figures for inflamed and carcinomatous tissue being 74% and 65%, respectively. ERα labelling was seen in 85% of epithelial cells in normal prostate glands, the corresponding figures for hyperplastic, inflamed and neoplastic glands being 35%, 22% and 12%, respectively. ERβ labelling was seen in 85% of epithelial cells of normal glands and in about 70% of such cells in glands showing pathological changes. On the other hand, PR expression (weak) in normal glands was observed in fewer epithelial cells (44%) than in hyperplastic (70%), inflamed (62%) or neoplastic (64%) glands. [Copyright &y& Elsevier]

Blood component transfusion is a common procedure used during hospital admissions; however, it is not risk-free. The evaluation of correct use of blood products (BP) is of vast importance considering the risks and costs implied in their use. Our principal objective was to evaluate the adherence to national guidelines for blood transfusion in pediatric patients at a third level university hospital. A prospective and retrospective descriptive analytical study was conducted to report the incidence of incorrect use of BP in pediatric patients (1 month to 16 years of age). In a timeline period of 4 years, 579 medical records were randomly selected from a total of 6575 transfusions realized to create a statistically significant sample. The variables studied were volume, infusion time, and transfusion criteria. Indications were evaluated in patient's medical records according to national guidelines. Of the transfusions analyzed, 54% were classified as incorrect mainly due to lack of transfusion criteria fulfillment. Blood transfusion indications in pediatric patients adhered poorly to national guidelines. The implementation of effective programs for education and information on the use of BP are needed to increase compliance with current guidelines. [ABSTRACT FROM AUTHOR]